Deletion of the extracellular matrix glycoprotein ADAMTSL3 increases pro-fibrotic signalling and exacerbates heart failure in mice

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Karoline Bjarnesdatter Rypdal

Center For Clinical Heart Research, Oslo (Norway)

5 More presentations in this session

Presentation thumbnail

Target induction of heme oxygenase-1 attenuates anti-HLA I antibody induced transplant vasculopathy in an allogeneic aortic transplantation model in mice

Doctor L. Kummer (Heidelberg, DE)

Abstract Slides

Presentation thumbnail

Nitro-oxidative stress impairs single cardiomyocyte adrenergic reserve in a murine model of HFpEF.

Mr L. Semmler (Berlin, DE)

Abstract Slides

Presentation thumbnail

Treatment with activin type ii receptor antibody improves cardiac function in mice after myocardial infarction

Doctor W. Bao (Gaithersburg, US)

Abstract Slides

Presentation thumbnail

Sodium glucose co-transporter 2 inhibition prevents muscle energy metabolism changes in infarcted rats

Miss L. Souza (Botucatu, BR)

Abstract Slides

Presentation thumbnail

Takotsubo syndrome-like model in rats with high reproducibility and low mortality

Doctor E. Zulfaj (Gothenburg, SE)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure - Bench studies

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Coronary microvascular dysfunction in heart failure: observations from the MICRO registry

Congress Session

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources